Literature DB >> 21665128

Epidemiology of gout: an update.

E U R Smith1, C Díaz-Torné, F Perez-Ruiz, L M March.   

Abstract

Gout is the most common inflammatory joint disease in men, characterised by formation of monosodium urate (MSU) crystals in the synovial fluid of joints and in other tissues. The epidemiology of gout provides us with the understanding of the disease distribution and its determinants. In an attempt to update the knowledge on the topic, more recent research reports on the descriptive epidemiology of gout are reviewed in this article. The review describes clinical characteristics and case definitions of gout, including the Rome and New York diagnosis criteria of gout, '1977 American Rheumatism Association (ARA) criteria' and the 10 key propositions of the European League Against Rheumatism (EULAR) recommendations. Gout incidence, prevalence, morbidity and mortality, geographical variation of the disease, relevant risk factors for both the occurrence and outcome of gout and trends of the disease over time are then described. Difficulties in obtaining the information and data reported are also discussed. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21665128     DOI: 10.1016/j.berh.2010.10.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  41 in total

1.  Oxidative damage is present in plasma and circulating neutrophils 4 weeks after a high mountain expedition.

Authors:  Lucrecia Carrera-Quintanar; Miguel Lopez-Fuertes; Vicente Climent; Maria Herranz-Lopez; Vicente Micol; Antoni Pons; Francisco Sogorb; Enrique Roche
Journal:  Eur J Appl Physiol       Date:  2011-12-06       Impact factor: 3.078

2.  As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout.

Authors:  A-K Tausche; M Christoph; M Forkmann; U Richter; S Kopprasch; C Bielitz; M Aringer; C Wunderlich
Journal:  Rheumatol Int       Date:  2013-09-12       Impact factor: 2.631

Review 3.  Molecular basis of oxidative stress in gouty arthropathy.

Authors:  Yessica Zamudio-Cuevas; Cristina Hernández-Díaz; Carlos Pineda; Anthony M Reginato; Jorge Francisco Cerna-Cortés; Lucio Ventura-Ríos; Alberto López-Reyes
Journal:  Clin Rheumatol       Date:  2015-04-09       Impact factor: 2.980

4.  Investigation into the association between P2RX7 gene polymorphisms and susceptibility to primary gout and hyperuricemia in a Chinese Han male population.

Authors:  Ying Ying; Yong Chen; Zhen Li; Haiyan Huang; Qiongyao Gong
Journal:  Rheumatol Int       Date:  2017-02-27       Impact factor: 2.631

5.  Allopurinol use in a New Zealand population: prevalence and adherence.

Authors:  Simon Horsburgh; Pauline Norris; Gordon Becket; Bruce Arroll; Peter Crampton; Jacqueline Cumming; Shirley Keown; Peter Herbison
Journal:  Rheumatol Int       Date:  2014-01-04       Impact factor: 2.631

Review 6.  A Systematic Review of the Economic and Humanistic Burden of Gout.

Authors:  Gemma E Shields; Stephen M Beard
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

7.  Experiences of gout-related disability from the patients' perspective: a mixed methods study.

Authors:  Peter M ten Klooster; Harald E Vonkeman; Martijn A H Oude Voshaar; Christina Bode; Mart A F J van de Laar
Journal:  Clin Rheumatol       Date:  2014-08       Impact factor: 2.980

8.  Risk factors for gout developed from hyperuricemia in China: a five-year prospective cohort study.

Authors:  Yangang Wang; Shengli Yan; Changgui Li; Shihua Zhao; Jing Lv; Fang Wang; Dongmei Meng; Lin Han; Yunlong Wang; Zhimin Miao
Journal:  Rheumatol Int       Date:  2012-04-29       Impact factor: 2.631

Review 9.  The management of gout.

Authors:  Andrew Finch Rheumatology; Paul Kubler Rheumatologist
Journal:  Aust Prescr       Date:  2016-08-01

Review 10.  Gout tophus on an intradural fascicle: a case description.

Authors:  Nadine Willner; Camelia-Maria Monoranu; Christian Stetter; Ralf-Ingo Ernestus; Thomas Westermaier
Journal:  Eur Spine J       Date:  2015-11-10       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.